Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas: A single center experience

M. C. Miggiano, F. Gherlinzoni, G. Visani, A. Belardinelli, P. Ricci, G. Rosti, P. Mazza, M. R. Motta, S. Rizzi, R. M. Lemoli, P. L. Zinzani, S. Tura

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background. Both rhGM-CSF and rhG-CSF can accelerate hematological recovery after high-dose therapy and autologous bone marrow transplantation in patients with high grade non Hodgkin's lymphoma and reduce transplant-related morbidity after ABMT. Methods. The clinical course of 23 non randomized patients was analyzed and compared with a historical control group of 10 patients. Ten patients received GM-CSF at a dose of 10 μg/kg in a 6-h IV infusion, and 13 received G-CSF at a dose of 5 μg/kg subcutaneously. Control patients received no GFs. Results. Mean granulocytic recovery to 0.5 x 109/L was obtained 13.1 ± 3.2 days after marrow reinfusion in the G-CSF arm vs 16 ± 2.7 in GM-CSF pts (p = 0.03) and vs 19.6 ± 7.6 in controls (p <0.01); this reduction led to a statistically significant shorter duration of fever and parenteral antibiotic therapy. Platelet recovery to 20 x 109/L was not significantly influenced by GFs. Conclusions. These results indicate that only G-CSF accelerates hematological recovery after high-dose chemotherapy and autologous bone marrow transplantation and induces a significant decrease in terms of infection morbidity and duration of hospital stay.

Original languageEnglish
Pages (from-to)225-232
Number of pages8
JournalHaematologica
Volume79
Issue number3
Publication statusPublished - 1994

Fingerprint

Autologous Transplantation
Bone Marrow Transplantation
Non-Hodgkin's Lymphoma
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Morbidity
Length of Stay
Arm
Fever
Blood Platelets
Bone Marrow
Anti-Bacterial Agents
Transplants
Drug Therapy
Control Groups
Therapeutics
Infection

Keywords

  • autologous bone marrow transplantation
  • growth factors
  • high-grade non Hodgkin's lymphoma

ASJC Scopus subject areas

  • Hematology

Cite this

Miggiano, M. C., Gherlinzoni, F., Visani, G., Belardinelli, A., Ricci, P., Rosti, G., ... Tura, S. (1994). Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas: A single center experience. Haematologica, 79(3), 225-232.

Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas : A single center experience. / Miggiano, M. C.; Gherlinzoni, F.; Visani, G.; Belardinelli, A.; Ricci, P.; Rosti, G.; Mazza, P.; Motta, M. R.; Rizzi, S.; Lemoli, R. M.; Zinzani, P. L.; Tura, S.

In: Haematologica, Vol. 79, No. 3, 1994, p. 225-232.

Research output: Contribution to journalArticle

Miggiano, MC, Gherlinzoni, F, Visani, G, Belardinelli, A, Ricci, P, Rosti, G, Mazza, P, Motta, MR, Rizzi, S, Lemoli, RM, Zinzani, PL & Tura, S 1994, 'Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas: A single center experience', Haematologica, vol. 79, no. 3, pp. 225-232.
Miggiano MC, Gherlinzoni F, Visani G, Belardinelli A, Ricci P, Rosti G et al. Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas: A single center experience. Haematologica. 1994;79(3):225-232.
Miggiano, M. C. ; Gherlinzoni, F. ; Visani, G. ; Belardinelli, A. ; Ricci, P. ; Rosti, G. ; Mazza, P. ; Motta, M. R. ; Rizzi, S. ; Lemoli, R. M. ; Zinzani, P. L. ; Tura, S. / Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas : A single center experience. In: Haematologica. 1994 ; Vol. 79, No. 3. pp. 225-232.
@article{3f997ba42a0e41308a5a787a0f1cb9e9,
title = "Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas: A single center experience",
abstract = "Background. Both rhGM-CSF and rhG-CSF can accelerate hematological recovery after high-dose therapy and autologous bone marrow transplantation in patients with high grade non Hodgkin's lymphoma and reduce transplant-related morbidity after ABMT. Methods. The clinical course of 23 non randomized patients was analyzed and compared with a historical control group of 10 patients. Ten patients received GM-CSF at a dose of 10 μg/kg in a 6-h IV infusion, and 13 received G-CSF at a dose of 5 μg/kg subcutaneously. Control patients received no GFs. Results. Mean granulocytic recovery to 0.5 x 109/L was obtained 13.1 ± 3.2 days after marrow reinfusion in the G-CSF arm vs 16 ± 2.7 in GM-CSF pts (p = 0.03) and vs 19.6 ± 7.6 in controls (p <0.01); this reduction led to a statistically significant shorter duration of fever and parenteral antibiotic therapy. Platelet recovery to 20 x 109/L was not significantly influenced by GFs. Conclusions. These results indicate that only G-CSF accelerates hematological recovery after high-dose chemotherapy and autologous bone marrow transplantation and induces a significant decrease in terms of infection morbidity and duration of hospital stay.",
keywords = "autologous bone marrow transplantation, growth factors, high-grade non Hodgkin's lymphoma",
author = "Miggiano, {M. C.} and F. Gherlinzoni and G. Visani and A. Belardinelli and P. Ricci and G. Rosti and P. Mazza and Motta, {M. R.} and S. Rizzi and Lemoli, {R. M.} and Zinzani, {P. L.} and S. Tura",
year = "1994",
language = "English",
volume = "79",
pages = "225--232",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "3",

}

TY - JOUR

T1 - Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas

T2 - A single center experience

AU - Miggiano, M. C.

AU - Gherlinzoni, F.

AU - Visani, G.

AU - Belardinelli, A.

AU - Ricci, P.

AU - Rosti, G.

AU - Mazza, P.

AU - Motta, M. R.

AU - Rizzi, S.

AU - Lemoli, R. M.

AU - Zinzani, P. L.

AU - Tura, S.

PY - 1994

Y1 - 1994

N2 - Background. Both rhGM-CSF and rhG-CSF can accelerate hematological recovery after high-dose therapy and autologous bone marrow transplantation in patients with high grade non Hodgkin's lymphoma and reduce transplant-related morbidity after ABMT. Methods. The clinical course of 23 non randomized patients was analyzed and compared with a historical control group of 10 patients. Ten patients received GM-CSF at a dose of 10 μg/kg in a 6-h IV infusion, and 13 received G-CSF at a dose of 5 μg/kg subcutaneously. Control patients received no GFs. Results. Mean granulocytic recovery to 0.5 x 109/L was obtained 13.1 ± 3.2 days after marrow reinfusion in the G-CSF arm vs 16 ± 2.7 in GM-CSF pts (p = 0.03) and vs 19.6 ± 7.6 in controls (p <0.01); this reduction led to a statistically significant shorter duration of fever and parenteral antibiotic therapy. Platelet recovery to 20 x 109/L was not significantly influenced by GFs. Conclusions. These results indicate that only G-CSF accelerates hematological recovery after high-dose chemotherapy and autologous bone marrow transplantation and induces a significant decrease in terms of infection morbidity and duration of hospital stay.

AB - Background. Both rhGM-CSF and rhG-CSF can accelerate hematological recovery after high-dose therapy and autologous bone marrow transplantation in patients with high grade non Hodgkin's lymphoma and reduce transplant-related morbidity after ABMT. Methods. The clinical course of 23 non randomized patients was analyzed and compared with a historical control group of 10 patients. Ten patients received GM-CSF at a dose of 10 μg/kg in a 6-h IV infusion, and 13 received G-CSF at a dose of 5 μg/kg subcutaneously. Control patients received no GFs. Results. Mean granulocytic recovery to 0.5 x 109/L was obtained 13.1 ± 3.2 days after marrow reinfusion in the G-CSF arm vs 16 ± 2.7 in GM-CSF pts (p = 0.03) and vs 19.6 ± 7.6 in controls (p <0.01); this reduction led to a statistically significant shorter duration of fever and parenteral antibiotic therapy. Platelet recovery to 20 x 109/L was not significantly influenced by GFs. Conclusions. These results indicate that only G-CSF accelerates hematological recovery after high-dose chemotherapy and autologous bone marrow transplantation and induces a significant decrease in terms of infection morbidity and duration of hospital stay.

KW - autologous bone marrow transplantation

KW - growth factors

KW - high-grade non Hodgkin's lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0027993846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027993846&partnerID=8YFLogxK

M3 - Article

C2 - 7926971

AN - SCOPUS:0027993846

VL - 79

SP - 225

EP - 232

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 3

ER -